Payne Fletcher's Form 4 filing
Aptose Biosciences Inc. (APTO) · filed Jul 1, 2026
- Accession no.
- 0000912282-26-000895
- Filed
- Jul 1, 2026, 4:49 PM ET
- Trade date
- Jun 30, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 3 derivative transactions. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Payne FletcherCIK 0001650476 | Other: FORMER SVP AND CFO |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 30, 2026 | Common Shares | DReturned to the companyDisposed | −55,000 | $0.00 | $0 | 0 | Direct | |
| Jun 30, 2026 | Common Shares | DReturned to the companyDisposed | −200,000 | $0.00 | $0 | 0 | Direct | |
| Jun 30, 2026 | Common Stock | DReturned to the companyDisposed | −1,000,000 | $0.00 | $0 | 0 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Converted from Canadian price of C$2.41 per share using an exchange rate of C$1.4 = US$1.00.
Referenced by the price of 2 transactions in Table I.
Remarks
TOTAL OPTIONS AND OPTION EXERCISE PRICE SUBJECT TO ADJUSTMENT AS A RESULT OF THE ISSUER'S 1:30 REVERSE STOCK SPLIT ON 2/25/2025 AND 1:15 REVERSE SPLIT ON 6/6/2023